Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Ruierli Bioengineering is a biotechnology company based in Xi'an, China, specializing in the development and manufacture of in vitro diagnostic (IVD) reagents and medical devices. Founded in 2003, the company focuses on providing high-quality diagnostic solutions for clinical laboratories and research institutions, particularly in the fields of immunology and biochemistry. Its product portfolio includes ELISA kits, rapid diagnostic tests, and laboratory instrumentation. The company operates under ISO and GMP standards to ensure the reliability of its biological products for the healthcare market. It is recognized as a high-tech enterprise within the Shaanxi province and serves a broad domestic customer base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Ruierli Bioengineering.